NSAID-Related Psychiatric Adverse Events: Who is at Risk?

By Graziano Onder   Francesca Pellicciotti   Giovanni Gambassi   Roberto Bernabei  

Drugs, Vol. 64, Iss. 23, 2004-01 ,pp. : 2619-2627

Adis International

Access to resources Recommend Favorite

Risk Management and Outcomes of Adverse Events to Pioglitazone in Primary Care in the UK: An Observational Study

By Fogg Carole   Kasliwal Rachna   Shakir Saad A.W.  

Drug Safety, Vol. 32, Iss. 3, 2009-01 ,pp. : 229-237

Adis International

Access to resources Recommend Favorite

NSAID Use and the Risk of Parkinson's Disease: Systematic Review and Meta-Analysis of Observational Studies

By Samii Ali  

Drugs & Aging, Vol. 26, Iss. 9, 2009-09 ,pp. : 769-779

Adis International

Access to resources Recommend Favorite

Risk of Adverse Events with the Use of Augmentation Therapy for the Treatment of Resistant Depression

By Schweitzer I.   Tuckwell V.  

Drug Safety, Vol. 19, Iss. 6, 1998-12 ,pp. : 455-464

Adis International

Access to resources Recommend Favorite

Complementary Medicines Use by Australian Veterans

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 35, Iss. 2, 2005-06 ,pp. : 110-111

John Wiley & Sons Inc

Access to resources Recommend Favorite